Búsqueda

The Impact of direct-to-consumer advertising on health insurance markets

Recurso electrónico / electronic resource
Registro MARC
Tag12Valor
LDR  00000cab a2200000 4500
001  MAP20140042159
003  MAP
005  20141205101318.0
008  141114e20141006esp|||p |0|||b|spa d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎344.1
24504‎$a‎The Impact of direct-to-consumer advertising on health insurance markets‎$c‎William Encinosa...[et.al]
520  ‎$a‎Direct-to-consumer advertising (DTCA) for drugs has increased from US$200 million in 1997 to US$4 billion in 2011. While studies show that DTCA impacts the patient-physician relationship, little is known of the effect of DTCA on health insurance markets. We test whether DTCA raises the costs in these markets or makes the markets more efficient in drug pricing. Across 212 markets, we examine the impact of DTCA on insurers' negotiated prices for 166 drugs. Controlling for unobserved pharmacy and pharmacy benefit manager attributes, as well as manufacturer advertising market selection effects, we find that an increase in a manufacturer's DTCA spending lowers insurer prices and reduces insurance market price dispersion. These competitive effects intensify as DTCA competition increases between drug manufacturers.
650 4‎$0‎MAPA20080626310‎$a‎Seguro de asistencia sanitaria
650 4‎$0‎MAPA20080590567‎$a‎Empresas de seguros
650 4‎$0‎MAPA20080592578‎$a‎Política de precios
650 4‎$0‎MAPA20080606633‎$a‎Industria farmacéutica
650 4‎$0‎MAPA20080621919‎$a‎Precios de los medicamentos
650 4‎$0‎MAPA20080556020‎$a‎Publicidad
650 4‎$0‎MAPA20110017224‎$a‎Consumidores
650 4‎$0‎MAPA20080579784‎$a‎Costes económicos
650 4‎$0‎MAPA20080586294‎$a‎Mercado de seguros
7730 ‎$w‎MAP20077100215‎$t‎Geneva papers on risk and insurance : issues and practice‎$d‎Geneva : The Geneva Association, 1976-‎$x‎1018-5895‎$g‎06/10/2014 Volumen 39 Número 4 - octubre 2014 , p. 749-767